المؤلفون: Takaba R; Department of Chemical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan, 468-8502. 140973239@ccalumni.meijo-u.ac.jp., Ibi D; Department of Chemical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan, 468-8502. ibid@meijo-u.ac.jp.; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502. ibid@meijo-u.ac.jp., Yoshida K; Department of Medical Chemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Hosomi E; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Kawase R; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Kitagawa H; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Goto H; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Achiwa M; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Mizutani K; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Maeda K; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., González-Maeso J; Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA., Kitagaki S; Department of Medical Chemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502., Hiramatsu M; Department of Chemical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan, 468-8502. mhiramt@meijo-u.ac.jp.; Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 468-8502. mhiramt@meijo-u.ac.jp.

المصدر: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 May; Vol. 397 (5), pp. 3019-3035. Date of Electronic Publication: 2023 Oct 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/*analogs & derivatives, Antidepressive Agents*/pharmacology , Hallucinogens*/pharmacology , Mice, Inbred C57BL* , Receptor, Serotonin, 5-HT2A*/metabolism , Receptor, Serotonin, 5-HT2A*/drug effects , Amphetamines*/pharmacology , Psilocybin*/pharmacology , Bridged Bicyclo Compounds* , Methylamines*, Animals ; Male ; Behavior, Animal/drug effects ; Motor Activity/drug effects ; Mice ; Anti-Anxiety Agents/pharmacology ; Serotonin 5-HT2 Receptor Agonists/pharmacology ; Swimming ; Depression/drug therapy

المؤلفون: Gomonit MM; Department of Forensic Science, College of Criminal Justice, Sam Houston State University, Huntsville, Texas, USA., Skillman B; Department of Forensic Science, College of Criminal Justice, Sam Houston State University, Huntsville, Texas, USA., Swortwood MJ; Department of Forensic Science, College of Criminal Justice, Sam Houston State University, Huntsville, Texas, USA.; Robson Forensic, Denver, Colorado, USA.

المصدر: Journal of forensic sciences [J Forensic Sci] 2024 Mar; Vol. 69 (2), pp. 678-687. Date of Electronic Publication: 2023 Dec 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Pub Country of Publication: United States NLM ID: 0375370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-4029 (Electronic) Linking ISSN: 00221198 NLM ISO Abbreviation: J Forensic Sci Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/*analogs & derivatives, Psilocybin*/analysis , Tandem Mass Spectrometry*/methods, Humans ; Chromatography, Liquid/methods ; Liquid Chromatography-Mass Spectrometry

المؤلفون: Jackson ES; Department of Communicative Sciences and Disorders, New York University, USA. Electronic address: eric.s.jackson@nyu.edu., Goldway N; Department of Psychology, New York University, USA., Gerlach-Houck H; Department of Speech, Language, and Hearing Sciences, Western Michigan University, USA., Gold ND; Department of Psychiatry, New York University Langone Health, USA.

المصدر: Journal of fluency disorders [J Fluency Disord] 2024 Sep; Vol. 81, pp. 106062. Date of Electronic Publication: 2024 May 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7601744 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-801X (Electronic) Linking ISSN: 0094730X NLM ISO Abbreviation: J Fluency Disord Subsets: MEDLINE

مواضيع طبية MeSH: Hallucinogens*/administration & dosage , Hallucinogens*/therapeutic use , Stuttering*/drug therapy , Self Report* , Psilocybin*/pharmacology , Psilocybin*/administration & dosage, Humans ; Male ; Female ; Lysergic Acid Diethylamide/pharmacology ; Lysergic Acid Diethylamide/administration & dosage ; Adult

المؤلفون: Sakai K; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA.; San Francisco Veterans Affairs Medical Center, San Francisco, CA, 94121, USA., Bradley ER; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA. Ellen.bradley@ucsf.edu.; San Francisco Veterans Affairs Medical Center, San Francisco, CA, 94121, USA. Ellen.bradley@ucsf.edu., Zamaria JA; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA.; School of Education, University of California, Berkeley, Berkeley, CA, 94720, USA., Agin-Liebes G; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA., Kelley DP; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA.; San Francisco Veterans Affairs Medical Center, San Francisco, CA, 94121, USA., Fish A; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA., Martini V; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA.; Psychology Department, Palo Alto University, Palo Alto, CA, 94304, USA., Ferris MC; Psychology Department, Palo Alto University, Palo Alto, CA, 94304, USA., Morton E; Department of Psychiatry, University of British Columbia, Vancouver, BC, V6T 2A1, Canada., Michalak EE; Department of Psychiatry, University of British Columbia, Vancouver, BC, V6T 2A1, Canada., O'Donovan A; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA.; San Francisco Veterans Affairs Medical Center, San Francisco, CA, 94121, USA., Woolley JD; Department of Psychiatry and Behavioral Science, University of California, San Francisco, San Francisco, CA, 94143, USA.; San Francisco Veterans Affairs Medical Center, San Francisco, CA, 94121, USA.

المصدر: Psychopharmacology [Psychopharmacology (Berl)] 2024 Aug; Vol. 241 (8), pp. 1617-1630. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/administration & dosage , Psilocybin*/pharmacology , Selective Serotonin Reuptake Inhibitors*/administration & dosage , Selective Serotonin Reuptake Inhibitors*/pharmacology , Hallucinogens*/administration & dosage , Hallucinogens*/pharmacology , Agaricales* , Drug Interactions*, Humans

المؤلفون: Korthuis PT; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA., Hoffman K; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA., Wilson-Poe AR; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA.; Legacy Research Institute, Legacy Health, Portland, OR, USA., Luoma JB; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA.; Portland Psychotherapy Clinic, Research, & Training Center, Portland, OR, USA., Bazinet A; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA.; Sequoia Center, Portland, OR, USA., Pertl K; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA., Morgan DL; Department of Sociology, Portland State University, Portland, OR, USA., Cook RR; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA., Bielavitz S; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA., Myers R; Oregon Health & Science University, Portland, OR, USA., Wolf RC; Subtance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Rockville, MD, USA., McCarty D; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA., Stauffer CS; Oregon Health & Science University, Portland, OR, USA.; The Open Psychedelic Evaluation Nexus (OPEN), Portland, OR, USA.; Portland VA Medical Center, Portland, OR, USA.

المصدر: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Aug; Vol. 38 (8), pp. 761-768. Date of Electronic Publication: 2024 Jun 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/pharmacology , Psilocybin*/administration & dosage , Hallucinogens*/administration & dosage , Hallucinogens*/therapeutic use , Hallucinogens*/adverse effects , Consensus*, Humans ; Female ; Male ; Adult ; Oregon ; Colorado ; Middle Aged ; Surveys and Questionnaires

المؤلفون: Chisamore N; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: noah.chisamore2@uhn.ca., Johnson D; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: danica.johnson@uhn.ca., Chen MJQ; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Johns Hopkins University, Baltimore, MD, United States. Electronic address: mchen149@jhu.edu., Offman H; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: offmanh@rogers.com., Chen-Li D; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: david.chen-li@uhn.ca., Kaczmarek ES; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: erica.kaczmarek@uhn.ca., Doyle Z; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Canadian Rapid Treatment Centre of Excellence, Mississauga, ON, Canada. Electronic address: zoe.doyle@uhn.ca., McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Canadian Rapid Treatment Centre of Excellence, Mississauga, ON, Canada. Electronic address: roger.mcintyre@bcdf.org., Rosenblat JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: joshua.rosenblat@uhn.ca.

المصدر: Journal of psychiatric research [J Psychiatr Res] 2024 Aug; Vol. 176, pp. 77-84. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Systematic Review; Review

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 0376331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1379 (Electronic) Linking ISSN: 00223956 NLM ISO Abbreviation: J Psychiatr Res Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/administration & dosage , Psilocybin*/pharmacology , Psychotherapy*/methods , Hallucinogens*/administration & dosage, Humans ; Depression/therapy ; Depression/drug therapy ; Clinical Protocols ; Depressive Disorder/therapy ; Depressive Disorder/drug therapy

المؤلفون: Polito V; School of Psychological Sciences, Macquarie University, Sydney, NSW, Australia., Liknaitzky P; Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Australia.

المصدر: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Aug; Vol. 38 (8), pp. 701-711. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/administration & dosage , Psilocybin*/pharmacology , Hallucinogens*/administration & dosage , Hallucinogens*/pharmacology , Lysergic Acid Diethylamide*/administration & dosage , Lysergic Acid Diethylamide*/pharmacology , Placebo Effect* , Dose-Response Relationship, Drug*, Humans ; Randomized Controlled Trials as Topic

المؤلفون: Kaminski D; The University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA., Reinert JP; The University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA.

المصدر: The Annals of pharmacotherapy [Ann Pharmacother] 2024 Aug; Vol. 58 (8), pp. 811-826. Date of Electronic Publication: 2023 Oct 30.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/adverse effects , Psilocybin*/therapeutic use , Hallucinogens*/adverse effects , Hallucinogens*/therapeutic use , Substance-Related Disorders* , Mental Disorders*/drug therapy, Humans

المؤلفون: Appiani FJ; Bioethics Committee, Hospital de Clínicas José de San Martín, Facultad de Ciencias Médicas, Universidad de Buenos Aires, Buenos Aires, Argentina.; Departamento de Psiquiatría y Salud Mental, Facultad de Ciencias Médicas, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina., Caroff SN; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA, USA.

المصدر: Current medical research and opinion [Curr Med Res Opin] 2024 Aug; Vol. 40 (8), pp. 1389-1396. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

مواضيع طبية MeSH: Hallucinogens*/therapeutic use , Hallucinogens*/adverse effects , Psilocybin*/therapeutic use , Psilocybin*/adverse effects, Humans ; Psychotherapy/methods

عنوان ترانسليتريتد: Tratamiento con microdosis de hongos con psilocibina en trastorno depresivo mayor: reporte de un caso.

المؤلفون: Zarankin M; Psiquiatra, práctica privada, Ciudad Autónoma de Buenos Aires, Argentina. dramarianazarankin@gmail.com., Pellegrini MS; Neurocirujana, práctica privada, Ciudad Autónoma de Buenos Aires, Argentina.. dramarianazarankin@gmail.com., Zenteno F; Licenciado en Psicología, práctica privada, Región de Araucania, Chile.. dramarianazarankin@gmail.com.

المصدر: Vertex (Buenos Aires, Argentina) [Vertex] 2024 Jul 10; Vol. 35 (164, abr.-jun.), pp. 33-39. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article; Case Reports; English Abstract

بيانات الدورية: Publisher: Polemos Country of Publication: Argentina NLM ID: 9440528 Publication Model: Electronic Cited Medium: Print ISSN: 0327-6139 (Print) Linking ISSN: 03276139 NLM ISO Abbreviation: Vertex Subsets: MEDLINE

مواضيع طبية MeSH: Psilocybin*/therapeutic use , Psilocybin*/administration & dosage , Depressive Disorder, Major*/drug therapy , Hallucinogens*/therapeutic use , Hallucinogens*/administration & dosage, Humans ; Young Adult ; Male ; Agaricales